Chiara Camisaschi

Author PubWeight™ 4.69^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides.	Clin Cancer Res	2012	1.15
2	Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity.	Cancer Res	2006	0.95
3	Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses.	J Immunol	2008	0.92
4	Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.	Cancer Res	2014	0.88
5	Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.	J Immunol	2008	0.83